Amneal’s Chirag Patel Chairs AAM Board
Replaces Lupin’s Alok Sonig As US Association Announces Fresh Leadership
Amneal president and co-CEO Chirag Patel has been named as chair of the AAM’s board of directors, as the US generics and biosimilars industry association unveiled leadership changes on the first day of its Access! 2022 annual meeting.
You may also be interested in...
AAM Names Teva’s Baeder Chair As It Kicks Off Annual Meeting
Christine Baeder has become chair of the AAM’s board, with the Teva executive welcomed to role as the US industry association kicked off its annual Access! conference in Orlando.
Teva’s Baeder: We Need To ‘Crack The Nut’ Of Complex Generics
Industry and regulators need to collaborate to provide complex generics with the opportunity to build even further on the significant contributions already made by off-patent medicines to savings and access, Christine Baeder, senior vice president and chief operating officer of Teva’s US generics division, tells Generics Bulletin in the first part of an exclusive interview.
AAM Reshuffles Board For 2021
US off-patent industry association the AAM has announced a fresh board of directors and officers for 2021, reflecting local management changes at multiple leading generics and biosimilars firms.